BCX7353-204 An open label study to evaluate the long-term safety of daily oral BCS7353 in subjects with Type I and II hereditary angioedema
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Biocryst Corporation
Start Date
September 18, 2019
End Date
August 31, 2023
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Biocryst Corporation
Start Date
September 18, 2019
End Date
August 31, 2023